Thomas J. Prins

1.9k total citations
19 papers, 1.1k citations indexed

About

Thomas J. Prins is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas J. Prins has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 10 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas J. Prins's work include Viral Infections and Immunology Research (8 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (3 papers). Thomas J. Prins is often cited by papers focused on Viral Infections and Immunology Research (8 papers), Chemical Synthesis and Analysis (5 papers) and Click Chemistry and Applications (3 papers). Thomas J. Prins collaborates with scholars based in United States. Thomas J. Prins's co-authors include Peter S. Dragovich, Ru Zhou, Amy K. Patick, Stephen T. Worland, Stewart L. Fisher, Barbara Imperiali, James W. Meador, Shella A. Fuhrman, David A. Matthews and L S Zalman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.

In The Last Decade

Thomas J. Prins

19 papers receiving 1.1k citations

Peers

Countries citing papers authored by Thomas J. Prins

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Prins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Prins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Prins more than expected).

Fields of papers citing papers by Thomas J. Prins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Prins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Prins. The network helps show where Thomas J. Prins may publish in the future.

Co-authorship network of co-authors of Thomas J. Prins

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Prins. A scholar is included among the top collaborators of Thomas J. Prins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Prins. Thomas J. Prins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Benzothiophene containing Rho kinase inhibitors: Efficacy in an animal model of glaucoma 2010 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Davis, Mehmet Kahraman, Thomas J. Prins, (unknown), (unknown), (unknown), Charmagne Cayanan, Elisabeth Gardiner, Marsha A. McLaughlin, Abbot F. Clark, Mark R. Hellberg, Andrew K. Shiau, Stewart A. Noble, Allen Borchardt	21
2	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics 2002 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Theodore Johnson, Edward L. Brown, (unknown), Shella A. Fuhrman, L S Zalman, Amy K. Patick, David A. Matthews, Xinjun Hou, James W. Meador, Rose Ann Ferre, Stephen T. Worland	63
3	Synthesis of an Optically Active, Bicyclic 2-Pyridone Dipeptide Mimetic 2002 ·The Journal of Organic Chemistry ·Peter S. Dragovich, Ru Zhou, Thomas J. Prins	14
4	Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Stephen E. Webber, Joseph Marakovits, Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Srinivasan Babu, (unknown), Clifford E. Ford, Mary A. Brothers, (unknown), James W. Meador, Rose Ann Ferre, Stephen T. Worland	10
5	Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Ru Zhou, Stephen E. Webber, Thomas J. Prins, Annette K. Kwok, Kōji Okano, Shella A. Fuhrman, L S Zalman, (unknown), Edward L. Brown, James W. Meador, Amy K. Patick, Clifford E. Ford, Mary A. Brothers, Susan L. Binford, David A. Matthews, Rose Ann Ferre, Stephen T. Worland	32
6	Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor 2000 ·Antimicrobial Agents and Chemotherapy ·L S Zalman, M. A. Brothers, Peter S. Dragovich, Ru Zhou, Thomas J. Prins, Stephen T. Worland, Amy K. Patick	45
7	Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids 1999 ·Bioorganic & Medicinal Chemistry Letters ·Peter S. Dragovich, Stephen E. Webber, Thomas J. Prins, Ru Zhou, Joseph Marakovits, Jayashree Tikhe, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Clifford E. Ford, Edward L. Brown, Susan L. Binford, James W. Meador, Rose Ann Ferre, Stephen T. Worland	18
8	Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes 1999 ·Proceedings of the National Academy of Sciences ·David A. Matthews, Peter S. Dragovich, S. E. Webber, Shella A. Fuhrman, Amy K. Patick, L S Zalman, Thomas F. Hendrickson, Robert A. Love, Thomas J. Prins, Joseph Marakovits, Ru Zhou, Jayashree Tikhe, C. E. Ford, James W. Meador, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, M. A. Brothers, Dorothy M. DeLisle, Stephen T. Worland	243
9	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 3. Structure−Activity Studies of Ketomethylene-Containing Peptidomimetics 1999 ·Journal of Medicinal Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Clifford E. Ford, James W. Meador, Rose Ann Ferre, Stephen T. Worland	54
10	In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease 1999 ·Antimicrobial Agents and Chemotherapy ·Amy K. Patick, Susan L. Binford, M. A. Brothers, Raven Jackson, C. E. Ford, Matthias Diem, Fausto Maldonado, Peter S. Dragovich, Ru Zhou, Thomas J. Prins, Shella A. Fuhrman, James W. Meador, L S Zalman, David A. Matthews, Stephen T. Worland	175
11	Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 4. Incorporation of P₁ Lactam Moieties as l-Glutamine Replacements 1999 ·Journal of Medicinal Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Stephen E. Webber, Joseph Marakovits, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Clifford E. Ford, Benjamin J. Burke, Paul A. Rejto, Thomas F. Hendrickson, Tove Tuntland, Edward L. Brown, James W. Meador, Rose Ann Ferre, (unknown), Maha Kosa, Stephen T. Worland	139
12	Formal, Stereoselective Synthesis of Hydroxyethylene Dipeptide Isosteres Utilizing Pseudoephedrine Amides 1997 ·The Journal of Organic Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou	12
13	Structure-Based Design of Novel, Urea-Containing FKBP12 Inhibitors 1996 ·Journal of Medicinal Chemistry ·Peter S. Dragovich, (unknown), (unknown), (unknown), Vincent J. Kalish, Charles R. Kissinger, Daniel R. Knighton, Cristina Lewis, Ellen W. Moomaw, Hans E. Parge, Laura A. Pelletier, Thomas J. Prins, Richard E. Showalter, John H. Tatlock, Kathleen D. Tucker, J. Ernest Villafranca	49
14	Palladium Catalyzed, Regioselective Reduction of 1,2-Epoxides by Ammonium Formate 1995 ·The Journal of Organic Chemistry ·Peter S. Dragovich, Thomas J. Prins, Ru Zhou	26
15	Chemoenzymic synthesis of 2-amino-3-(2,2'-bipyridinyl)propanoic acids 1993 ·The Journal of Organic Chemistry ·Barbara Imperiali, Thomas J. Prins, Stewart L. Fisher	69
16	A conformational study of peptides with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2: spectroscopic evidence for a peptide with significant .beta.-turn character in water and in dimethyl sulfoxide 1992 ·Journal of the American Chemical Society ·Barbara Imperiali, Rex Moats, Stewart L. Fisher, Thomas J. Prins	100
17	Hafnium halide compounds of methyl substituted allyl ligands. Synthesis, crystal structure and dynamics of (η5-C5Me5)(η3-1,2,3-Me3allyl)HfBr2 and (η5-C5Me5)(η3-1,1,2-Me3allyl)HfBr2 1991 ·Inorganica Chimica Acta ·(unknown), (unknown), Thomas J. Prins, (unknown), (unknown), (unknown), John C. Huffman	4
18	Effect of allyl methyl substituents on the preparation, dynamics, and reactivity of zirconium complexes (.eta.5-C5Me5)(allyl)ZrX2 (X = Cl, Br): structure of (.eta.5-C5Me5)(C3H5)ZrCl2 and (.eta.5-C5Me5)(1,2-Me2(butadiene))(.eta.2-CH2PPh2)Zr. Dynamics of (.eta.5-C5Me5)(2,3-Me2(butadiene))(.eta.2-CH2PPh2)Zr 1991 ·Organometallics ·(unknown), Thomas J. Prins, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Richard S. Kelly	12
19	Cyclopentadienyl(allyl)(butadiene)hafnium compounds. Synthesis, crystal structure, and dynamics of cyclopentadienyl(1,2,3-trimethylallyl)(1,2-dimethylbutadiene)hafnium and cyclopentadienyl(1,1,2-trimethylallyl)(2,3-dimethylbutadiene)hafnium 1991 ·Organometallics ·Thomas J. Prins, (unknown), (unknown), (unknown), (unknown), Jonathan O’Brien, (unknown), John C. Huffman	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact